Stress and the Sympathetic Nervous System in Adults With Depression
Primary Purpose
Major Depressive Disorder
Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Acute Stressors
Sponsored by
About this trial
This is an interventional basic science trial for Major Depressive Disorder
Eligibility Criteria
Inclusion Criteria:
- All participants will be 18-30 yrs.
- Healthy non-depressed men and women will have no history or evidence of psychiatric illness and will not have a family history of MDD or major psychiatric illness.
- Men and women with MDD will have symptomatic depression that meets diagnostic criteria and will be non-medicated.
- The capacity and willingness to provide written informed consent, to attend all study related visits, and to comply with the study protocol.
Exclusion Criteria:
Subjects will be excluded at the discretion of the PI/collaborating clinician or for any of the following reasons:
- psychiatric illness aside from MDD (including current or past psychotic disorders, bipolar disorder, schizophrenia or schizoaffective disorder, panic disorder, post-traumatic stress disorder, obsessive compulsive disorder)
- subthreshold depression
- current use of psychotropic medications (including major classes of antidepressants, anxiolytics, antipsychotics, mood stabilizers)
- active suicidal or homicidal ideation
- active substance dependence or eating disorders
- current use of any medications that could alter sympathetic reactivity
- diagnosed or suspected cardiovascular, renal, or metabolic disease (hypertension, heart disease, diabetes, hyperlipidemia)
- autonomic disorders
- tobacco use (including electronic cigarettes)
- obesity (body mass index > 30 kg/m2)
- breastfeeding or pregnancy
- <18 or >30 yrs
Sites / Locations
- The University of Texas at Arlington
Arms of the Study
Arm 1
Arm Type
Experimental
Arm Label
Assessment of Daily Stress Processes
Arm Description
Subjects will report cumulative exposure, perceived severity, and emotional responsiveness to commonly occurring everyday psychosocial stressors utilizing an ecological momentary assessment approach for 8 consecutive days.
Outcomes
Primary Outcome Measures
total number of daily stressors
measured each day via self-report using ecological momentary assessment
change in negative affect in response to daily stressors
measured each day via self-report using ecological momentary assessment
change in muscle sympathetic nerve activity in response to acute stress (compared to resting baseline activity)
measured using microneurography
Secondary Outcome Measures
Full Information
NCT ID
NCT04838262
First Posted
March 31, 2021
Last Updated
May 9, 2023
Sponsor
The University of Texas at Arlington
Collaborators
Penn State University
1. Study Identification
Unique Protocol Identification Number
NCT04838262
Brief Title
Stress and the Sympathetic Nervous System in Adults With Depression
Official Title
Daily Stress Processes and Sympathetic Reactivity in Depression
Study Type
Interventional
2. Study Status
Record Verification Date
May 2023
Overall Recruitment Status
Completed
Study Start Date
May 1, 2021 (Actual)
Primary Completion Date
April 27, 2023 (Actual)
Study Completion Date
April 27, 2023 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
The University of Texas at Arlington
Collaborators
Penn State University
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
To test our hypotheses, we will enroll healthy adults having no history of mood disorders and adults with major depressive disorder (MDD) having a broad range of depressive symptom severity. After screening, subjects will meet with the research coordinator or an investigator for a discussion, with opportunity for questions, before applicable consent forms are obtained. Daily stress processes will be assessed using an ecological momentary assessment approach for 8 consecutive days. On the last day of the daily stress assessment, we will directly measure muscle sympathetic nerve activity, blood pressure, and heart rate during acute laboratory-based cognitive, emotional, and physiological interventions to induce a stress response. A venous blood sample will be taken for measurements of metabolic and renal health and systemic inflammation.
Aim 1: To examine the effect of daily psychosocial stressor exposure on acute sympathetic stress reactivity in MDD. Two stressor exposure indicators will be calculated: stressor frequency (i.e., percentage of interview days during which at least one stressor occurred) and total stress (i.e., total number of stressors reported across all interview days) and will be related to the magnitude of responsiveness to the acute stress interventions. We hypothesize that the slope of this relation will be steeper in adults with MDD compared to healthy non-depressed adults.
Aim 2: To determine the relation between negative affective reactivity to daily psychosocial stressor exposure and acute sympathetic stress reactivity in MDD. Negative affective reactivity will be calculated as the change in affect on days when stressors occurred compared to one's typical affect on non-stressor days and will be related to the magnitude of responsiveness to the acute stress interventions. We hypothesize that the slope of this relation will be steeper in adults with MDD compared to healthy non-depressed adults.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Major Depressive Disorder
7. Study Design
Primary Purpose
Basic Science
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
94 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Assessment of Daily Stress Processes
Arm Type
Experimental
Arm Description
Subjects will report cumulative exposure, perceived severity, and emotional responsiveness to commonly occurring everyday psychosocial stressors utilizing an ecological momentary assessment approach for 8 consecutive days.
Intervention Type
Other
Intervention Name(s)
Acute Stressors
Intervention Description
Sympathetic nervous system activity and blood pressure will be measured before, during, and after several acute laboratory-based cognitive (Stroop Color Word Test), emotional (International Affective Picture System), and physiological (Cold Pressor Test) stressors.
Primary Outcome Measure Information:
Title
total number of daily stressors
Description
measured each day via self-report using ecological momentary assessment
Time Frame
8 days before intervention
Title
change in negative affect in response to daily stressors
Description
measured each day via self-report using ecological momentary assessment
Time Frame
8 days before intervention
Title
change in muscle sympathetic nerve activity in response to acute stress (compared to resting baseline activity)
Description
measured using microneurography
Time Frame
during laboratory-based intervention (3 minutes)
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
30 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
All participants will be 18-30 yrs.
Healthy non-depressed men and women will have no history or evidence of psychiatric illness and will not have a family history of MDD or major psychiatric illness.
Men and women with MDD will have symptomatic depression that meets diagnostic criteria and will be non-medicated.
The capacity and willingness to provide written informed consent, to attend all study related visits, and to comply with the study protocol.
Exclusion Criteria:
Subjects will be excluded at the discretion of the PI/collaborating clinician or for any of the following reasons:
psychiatric illness aside from MDD (including current or past psychotic disorders, bipolar disorder, schizophrenia or schizoaffective disorder, panic disorder, post-traumatic stress disorder, obsessive compulsive disorder)
subthreshold depression
current use of psychotropic medications (including major classes of antidepressants, anxiolytics, antipsychotics, mood stabilizers)
active suicidal or homicidal ideation
active substance dependence or eating disorders
current use of any medications that could alter sympathetic reactivity
diagnosed or suspected cardiovascular, renal, or metabolic disease (hypertension, heart disease, diabetes, hyperlipidemia)
autonomic disorders
tobacco use (including electronic cigarettes)
obesity (body mass index > 30 kg/m2)
breastfeeding or pregnancy
<18 or >30 yrs
Facility Information:
Facility Name
The University of Texas at Arlington
City
Arlington
State/Province
Texas
ZIP/Postal Code
76010
Country
United States
12. IPD Sharing Statement
Plan to Share IPD
Yes
IPD Sharing Plan Description
Per the data sharing policy of the National Institute of Mental Health (NIMH), we will deposit all phenotypic, psychosocial stress, and sympathetic reactivity data from this study to the NIMH Data Archive. We will use standard data dictionaries (NIH Toolbox Cognition Battery, NIH Toolbox Emotion Battery, PHQ-9) and will collect the data necessary to generate global unique identifiers for each study subject.
Learn more about this trial
Stress and the Sympathetic Nervous System in Adults With Depression
We'll reach out to this number within 24 hrs